Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhongshan Zunlong Pharmaceutical Co., Ltd. is a specialized pharmaceutical manufacturer based in the Zhongshan Torch High-Tech Industrial Development Zone in Guangdong, China. Established in 1994, the company focuses on the development, production, and sale of chemical drugs, particularly in the fields of anti-infectives and respiratory medicine. Its core product line features high-quality antibiotics such as Cefaclor, Azithromycin, and Roxithromycin, which are marketed under the well-recognized Zunlong brand. The company operates advanced, GMP-certified production facilities capable of manufacturing various dosage forms, including capsules, tablets, and granules. As a designated high-tech enterprise, Zhongshan Zunlong Pharmaceutical emphasizes technical innovation and stringent quality management to maintain its competitive position in the Chinese domestic market. The firm also explores international opportunities through its export-oriented manufacturing capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongshan Zunlong Pharmaceutical.